针对SHP2:结直肠癌治疗中的双重突破 - - 从信号通路调制到免疫微环境重塑
1Department of Pathology, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang Province, China.
World journal of gastrointestinal oncology
|July 23, 2025
概括
向SHP2 (一种氨酸酸酶) 提供了通过调节瘤生长信号和重编程瘤微环境来治疗结直肠癌 (CRC) 的双重策略. 在CRC治疗的临床试验中,SHP2抑制剂正在取得进展.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- SHP2是一种在结肠直肠癌 (CRC) 中过度表达的瘤性铁酸酶.
- SHP2通过调解受体氨酸激酶 (RTK) 信号通路 (RAS/ERK,JAK/STAT,PI3K/AKT) 来促进CRC进展.
- 通过影响T细胞透和与瘤相关的巨细胞,SHP2有助于免疫抑制瘤微环境 (TME).
研究的目的:
- 突出SHP2作为CRC的双重治疗目标.
- 强调SHP2在RTK信号和TME调制中的作用.
- 为了强调SHP2抑制剂在CRC治疗中的临床相关性.
主要方法:
- 审查SHP2在CRC瘤发生和TME中的作用.
- 对SHP2参与关键信号通路的分析.
- 在临床前和临床环境中评估SHP2抑制剂.
主要成果:
- 过度表达SHP2与CRC患者的预后不佳有关.
- 准SHP2同时影响瘤信号和TME.
- SHP2抑制剂显示出作为单疗法和组合治疗的前景.
结论:
- SHP2是CRC精密瘤学的关键分子标.
- SHP2充当免疫调节节点,使其成为CRC治疗的高优先目标.
- SHP2抑制剂代表了结直肠癌的有前途的治疗策略.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664


